|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evolution of gastric surgery techniques and outcomes显示文摘Surgical management of gastric cancer improves survival.However,for some time,surgeons have had diverse opinions about the extent of gastrectomy.Researchers have conducted many clinical studies,making slow but steady progress in determining the optimal surgical approach.The extent of lymph node dissection has been one of the major issues in surgery for gastric cancer.Many trials demonstrated that D2 dissection resulted in greater morbidity and mortality than D1 dissection.However,long-term outcomes demonstrated that D2 dissection resulted in longer survival than D1 dissection.In 2004,the Japan Clinical Oncology Group reported a pivotal trial which was performed to determine whether para-aortic lymph node dissection combined with D2 dissection was superior to D2 dissection alone and found no benefit of the additional surgery.Gastrectomy with pancreatectomy,splenectomy,and bursectomy was initially recommended as part of the D2 dissection.Now,pancreas-preserving total gastrectomy with D2 dissection is standard,and ongoing trials are addressing the role of splenectomy.Furthermore,the feasibility and safety of laparoscopic gastrectomy are well established.Survival and quality of life are increasingly recognized as the most important endpoints.In this review,we present perspectives on surgical techniques and important trials of these techniques in gastric cancer patients. | Hironori Shiozaki Yusuke Shimodaira Elena Elimova Roopma Wadhwa Kazuki Sudo Kazuto Harada Jeannelyn S.Estrella Prajnan Das Brian Badgwell Jaffer A.Ajani | 2016 | Chinese Journal of Cancer2016，35，8： | 9 |
| 2 | Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas显示文摘 | Kim L.Wang Tsung‐TehWu In SeonChoi HuaminWang ErikaResetkova Arlene M.Correa Wayne L.Hofstetter Stephen G.Swisher Jaffer A.Ajani AsifRashid Constance T.Albarracin | 2007 | Cancer2007，，4： | 2 |
| 3 | Prognostic significance of differentially expressed miRNAs in esophageal cancer显示文摘 | YuxinHu Arlene M.Correa AshrafulHoque BaoxiangGuan FeiYe JieHuang Stephen G.Swisher Tsung TehWu Jaffer A.Ajani Xiao‐ChunXu | 2010 | Int J Cancer2010，，1： | 2 |
| 4 | Prognostic significance of differentially expressed miRNAs in esophageal cancer显示文摘 | YuxinHu Arlene M.Correa AshrafulHoque BaoxiangGuan FeiYe JieHuang Stephen G.Swisher Tsung TehWu Jaffer A.Ajani Xiao‐ChunXu | 2010 | Int. J. Cancer2010，，1： | 1 |
| 5 | Prognostic significance of differentially expressed miRNAs in esophageal cancer显示文摘 | YuxinHu Arlene M.Correa AshrafulHoque BaoxiangGuan FeiYe JieHuang Stephen G.Swisher Tsung TehWu Jaffer A.Ajani Xiao‐ChunXu | 2010 | Cancer2010，，1： | 1 |
| 6 | The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma显示文摘 | HetaJaveri LianchunXiao EricRohren Jeffrey H.Lee ZhongxingLiao WayneHofstetter DipenMaru Manoop S.Bhutani Stephen G.Swisher HomerMacapinlac XuemeiWang Jaffer A.Ajani | 2009 | Cancer2009，，22： | 1 |
| 7 | Prognostic significance of differentially expressed miRNAs in esophageal cancer显示文摘 | YuxinHu Arlene M.Correa AshrafulHoque BaoxiangGuan FeiYe JieHuang Stephen G.Swisher Tsung TehWu Jaffer A.Ajani Xiao‐ChunXu | 2010 | Int J Cancer2010，，1： | 1 |
| 8 | Chemotherapy with 5‐fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma显示文摘 | Michael J.Overman ScottKopetz SijinWen Paulo M.Hoff DavidFogelman JeffreyMorris James L.Abbruzzese Jaffer A.Ajani Robert A.Wolff | 2008 | Cancer2008，，8： | 1 |
| 9 | Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas显示文摘 | Kim L.Wang Tsung‐TehWu In SeonChoi HuaminWang ErikaResetkova Arlene M.Correa Wayne L.Hofstetter Stephen G.Swisher Jaffer A.Ajani AsifRashid Constance T.Albarracin | 2007 | Cancer2007，，4： | 1 |
| 10 | Recent trend in gastric cancer treatment in the USA显示文摘Gastric adenocarcinoma(GAC)is estimated as the fifteenth most common cancer in the USA.Incidence rate has been gradually decreasing,but prognosis remains dismal.For patients with locally advanced GAC(stage>T1B and | Kazuto Harada Hideo Baba Jaffer A.Ajani | 2018 | Journal of Cancer Metastasis and Treatment2018，4，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员